用链接的DNA标记物对亨廷顿病进行预测测试
Lancet (London, England)
|August 26, 1989
概括
新的DNA标记物显著提高了亨廷顿病 (HD) 预测测试的准确性. 这一进步使得风险家庭中更可靠的症状前和产前排除测试成为可能.
科学领域:
- 遗传学 是一个遗传学.
- 神经学 神经学
- 分子生物学分子生物学
背景情况:
- 亨廷顿病 (HD) 是一种进展性神经退行性疾病,具有重要的遗传成分.
- 传统的HD遗传标志物,如G8 (D4S10) 探针,在预测准确性方面存在局限性.
- 改进的DNA标记器为遗传测试提供了更高的精度.
研究的目的:
- 评估亨廷顿病 (HD) 新型DNA标记物的预测准确度的提高.
- 评估这些标记物在症状前和产前排除测试中的有用性.
- 为了确定跨不同家庭结构的新标记的信息性.
主要方法:
- 使用了先进的DNA标记物,与HD位点有更紧密的联系.
- 对高风险的个体进行了预测性基因测试.
- 通过使用胆毛细胞活检样本进行产前排除测试.
主要成果:
- 新的DNA标记物提高了亨廷顿病 (HD) 测试的预测准确性.
- 在6个胆 ?? 样本的产前检测显示,有2例非传播和4个不确定的结果.
- 对44名成年人进行的测试表明,19人患HD风险增加,25人患HD风险降低.
- 苏格兰的家庭结构可以对大约75%的受影响个体进行测试.
结论:
- 新一代DNA标记物大大提高了亨廷顿病 (HD) 遗传测试的准确性和信息性.
- 这些标志物促进了更可靠的症状前和产前排除测试,有助于生殖和临床决策.
- 这些发现支持高级DNA标记物的广泛应用,用于HD遗传咨询和管理.
相关概念视频
Genetic Lingo
Overview
Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...


